NLS Pharmaceutics (NLSP) Institutional Ownership $1.42 -0.11 (-7.19%) As of 03:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NLS Pharmaceutics (NASDAQ:NLSP)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$30.15KNumber ofInstitutional Sellers(last 12 months)0 Get NLSP Insider Trade Alerts Want to know when executives and insiders are buying or selling NLS Pharmaceutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NLSP Institutional Buying and Selling by Quarter Remove Ads NLS Pharmaceutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC2,311,000$501K0.0%+6.4%19.618% 11/15/2023 Affinity Asset Advisors LLC200,455$140K0.0%-49.9%0.000% 8/21/2023 Affinity Asset Advisors LLC400,000$440K0.2%+16.2%0.000% 5/15/2023 Affinity Asset Advisors LLC344,089$520K0.2%N/A2.921% 11/16/2021 Two Sigma Securities LLC10,140$25K0.0%N/A0.086% 8/13/2021 Renaissance Technologies LLC41,997$132K0.0%N/A0.357% 5/20/2021Axiom Investment Management LLC68,000$273K0.1%N/A0.577% 5/18/2021 Millennium Management LLC33,213$134K0.0%N/A0.282% (Data available from 1/1/2016 forward)Remove Ads NLSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NLSP shares? During the previous two years, the following institutional investors and hedge funds held shares of NLS Pharmaceutics shares: Armistice Capital LLC ($501K), Affinity Asset Advisors LLC ($140K).Learn more on NLSP's institutional investors. Which institutional investors have been buying NLS Pharmaceutics stock? The following institutional investors have purchased NLS Pharmaceutics stock in the last 24 months: Affinity Asset Advisors LLC ($400K), and Armistice Capital LLC ($139K). How much institutional buying is happening at NLS Pharmaceutics? Institutional investors have bought a total of 539,000 shares in the last 24 months. This purchase volume represents approximately $614.67K in transactions. Which NLS Pharmaceutics major shareholders have been selling company stock? The following institutional investors have sold NLS Pharmaceutics stock in the last 24 months: Affinity Asset Advisors LLC ($199.55K). How much institutional selling is happening at NLS Pharmaceutics? Institutional investors have sold a total of 199,545 shares in the last 24 months. This volume of shares sold represents approximately $139.68K in transactions. Related Companies Finch Therapeutics Group Major Shareholders CEL-SCI Major Shareholders Cyclo Therapeutics Major Shareholders Chemomab Therapeutics Major Shareholders Natural Alternatives International Major Shareholders Lisata Therapeutics Major Shareholders NanoViricides Major Shareholders BioVie Major Shareholders Eagle Pharmaceuticals Major Shareholders Lakeshore Biopharma Major Shareholders This page (NASDAQ:NLSP) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NLS Pharmaceutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NLS Pharmaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NLSP Stock Free NLSP Stock Alerts